FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC, resulting in labeling updates for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Coreg (carvedilol)

Snippet

SUPPL AP for COREG (CARVEDILOL)